Document is current
Any future updates will be listed below
-
Authors
Serván-Mori, Edson https://orcid.org/0000-0001-9820-8325
Heredia-Pi, Ileana https://orcid.org/0000-0002-9998-9239
Guerrero-López, Carlos M. https://orcid.org/0000-0002-6405-5217
Jan, Stephen https://orcid.org/0000-0003-2839-1405
Downey, Laura https://orcid.org/0000-0002-9563-7113
Garcia-Díaz, Rocío https://orcid.org/0000-0003-1726-2456
Nigenda, Gustavo https://orcid.org/0000-0003-0067-0664
Orozco-Núñez, Emanuel https://orcid.org/0000-0002-6550-7385
de la Cruz Muradás-Troitiño, María https://orcid.org/0009-0005-9201-725X
Flamand, Laura https://orcid.org/0000-0003-1805-1423
Norton, Robyn https://orcid.org/0000-0002-3988-315X
Lozano, Rafael https://orcid.org/0000-0002-7356-8823
-
Funding
Funding for this research was provided by:
The Mexican Association of Pharmaceutical Research Industries, A.C. (CI-507-2022/CB22-173)
- License Information
-
More Information
Article History
Received: 30 March 2024
Accepted: 22 August 2024
First Online: 29 September 2024
Declarations
:
: Not applicable. This study involved no human participants, and was approved by the Research, Biosafety and Ethics Committees of the National Institute of Public Health in Mexico (ID: CI-507-2022/CB22-173).
: Not applicable.
: The authors declare that they have no competing interests.
